InflammX Therapeutics
Manufacturing · Florida, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
275 Bayshore Blvd Unit 1607, Tampa, Flor...Phone Number
(858) 480-2404Website
www.inflammx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About InflammX Therapeutics
InflammX Therapeutics is a clinical-stage company with highly differentiated, first-in-class products based upon a novel mechanism called Connexin43 (Cx43) Hemichannel Modulation. This mechanism leads to a differentiated treatment paradigm that modifies the dysregulated (NLRP3) inflammasome pathway of inflammation and its downstream pathology. InflammX is developing Xiflam, a small molecule for once-a-day oral administration. Xiflam has been shown to inhibit the pathologically open Cx43 hemichannel and modulate activation and dysregulation of the inflammasome resulting in perpetuated autoinflammation. InflammX Therapeutics is based in Tampa, Florida.Explore more
InflammX Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is InflammX Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
InflammX Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if InflammX Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at InflammX Therapeutics
Check out if InflammX Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on InflammX Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once InflammX Therapeutics has new funding data
Product Launch: Get notified when InflammX Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Check if InflammX Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to InflammX Therapeutics
Compare insights from companies similar to InflammX Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
InflammX Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
InflammX Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about InflammX Therapeutics.
InflammX Therapeutics Tech Stack
A closer look at the technologies used by InflammX Therapeutics
See more technologies
Most Recent Scoops
Left Company
Executive Move
Brian Levy, Chief Executive Officer, has recently left the organization to join Vitranu as Chief Executive Officer.
Executive Moves, Left Company
Person-Based
Person-Based
Person-Based
InflammX Therapeutics News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding InflammX Therapeutics
Sign Up For FreeTo access detailed company insights
InflammX Therapeutics is a clinical-stage company with highly differentiated, first-in-class products based upon a novel mechanism called Connexin43 (Cx43) Hemichannel Modulation. This mechanism leads to a differentiated treatment paradigm that modifies the dysregulated (NLRP3) inflammasome pathway of inflammation and its downstream pathology. Infl... Read More
